Ligand Pharmaceuticals (LGND) EBIT (2010 - 2026)
Ligand Pharmaceuticals (LGND) reported EBIT of $8.59 million for Q2 2026, up 1.7% from $8.44 million a year earlier but down 50.5% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) EBIT (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ligand Pharmaceuticals' EBIT came in at $94.73 million; for FY2025, it came in at $41 million.
- EBIT has a five-year compound annual growth rate of 1.8% (FY2020 to FY2025).
- By year, EBIT came in at -$22.61 million in FY2024, $11.94 million in FY2023 (+293.2%), $3.04 million in FY2022 (-97.1%) and $103.85 million in FY2021 (+176.9%).
- Five-year quarterly EBIT spans a low of -$36.22 million in Q1 2025 and a high of $54.93 million in Q3 2025.
- The high point for year-over-year EBIT in five years was Q1 2023 (growth of 566.0%); the low point was Q2 2022 (a decline of 81.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $17.37 million (Q1 2026), $13.84 million (Q4 2025) and $54.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Ligand Pharmaceuticals | 6.26 Bn | 2.72 Bn | - | 8.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.59 Mn |
| Mar 31, 2026 | 17.37 Mn |
| Dec 31, 2025 | 13.84 Mn |
| Sep 30, 2025 | 54.93 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Mar 31, 2025 | -36.22 Mn |
| Dec 31, 2024 | -9.64 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | -19.10 Mn |
| Mar 31, 2024 | 2.99 Mn |
| Dec 31, 2023 | -3.36 Mn |
| Sep 30, 2023 | 3.08 Mn |
| Jun 30, 2023 | -1.98 Mn |
| Mar 31, 2023 | 14.21 Mn |
| Dec 31, 2022 | -20.10 Mn |
| Sep 30, 2022 | 12.34 Mn |
| Jun 30, 2022 | 8.66 Mn |
| Mar 31, 2022 | 2.13 Mn |
| Dec 31, 2021 | 37.69 Mn |
| Sep 30, 2021 | 15.71 Mn |
API Access
Ligand Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();